These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 8636429

  • 21. Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides.
    Hara M, Iso-O N, Satoh H, Noto H, Togo M, Ishibashi S, Kimura S, Kadowaki T, Hashimoto Y, Tsukamoto K.
    Metabolism; 2006 Aug; 55(8):1129-34. PubMed ID: 16839851
    [Abstract] [Full Text] [Related]

  • 22. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC.
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [Abstract] [Full Text] [Related]

  • 23. Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies.
    Watts GF, Moroz P, Barrett PH.
    Metabolism; 2000 Sep; 49(9):1204-10. PubMed ID: 11016905
    [Abstract] [Full Text] [Related]

  • 24. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL.
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [Abstract] [Full Text] [Related]

  • 25. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW, van Vlijmen BJ, de Winther MP, van 't Hof B, van der Zee A, van der Boom H, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [Abstract] [Full Text] [Related]

  • 26. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.
    Post SM, Groenendijk M, Solaas K, Rensen PC, Princen HM.
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):768-74. PubMed ID: 14962946
    [Abstract] [Full Text] [Related]

  • 27. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA, Papachristou DJ, Kotsikogianni I, Giopanou I, Kypreos KE.
    FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
    [Abstract] [Full Text] [Related]

  • 28. Use of transgenic mice in lipoprotein metabolism and atherosclerosis research.
    Havekes LM, van Vlijmen BJ, Jong MC, van Dijk KW, Hofker MH.
    Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):463-6. PubMed ID: 9430397
    [Abstract] [Full Text] [Related]

  • 29. Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice.
    Volger OL, van der Boom H, de Wit EC, van Duyvenvoorde W, Hornstra G, Plat J, Havekes LM, Mensink RP, Princen HM.
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1046-52. PubMed ID: 11397718
    [Abstract] [Full Text] [Related]

  • 30. Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis.
    Huang Y, Schwendner SW, Rall SC, Sanan DA, Mahley RW.
    J Biol Chem; 1997 Sep 05; 272(36):22685-94. PubMed ID: 9312550
    [Abstract] [Full Text] [Related]

  • 31. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW, van Vlijmen BJ, van der Zee A, van't Hof B, van der Boom H, Kobayashi K, Chan L, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1998 Jan 05; 18(1):7-12. PubMed ID: 9445249
    [Abstract] [Full Text] [Related]

  • 32. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.
    Huang Y, Ji ZS, Brecht WJ, Rall SC, Taylor JM, Mahley RW.
    Arterioscler Thromb Vasc Biol; 1999 Dec 05; 19(12):2952-9. PubMed ID: 10591675
    [Abstract] [Full Text] [Related]

  • 33. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P, van den Maagdenberg AM, Boomsma DI, Stalenhoef AF, Smelt AH, Kastelein JJ, Marais AD, Frants RR, Havekes LM.
    J Clin Invest; 1994 Sep 05; 94(3):1252-62. PubMed ID: 8083367
    [Abstract] [Full Text] [Related]

  • 34. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS, Fazio S, Mahley RW.
    J Biol Chem; 1994 May 06; 269(18):13421-8. PubMed ID: 8175773
    [Abstract] [Full Text] [Related]

  • 35. Altered hepatic production of apolipoproteins B and E in the fasted septic rat: factors in the development of hypertriglyceridemia.
    Tripp RJ, Tabares A, Wang H, Lanza-Jacoby S.
    J Surg Res; 1993 Nov 06; 55(5):465-72. PubMed ID: 8231164
    [Abstract] [Full Text] [Related]

  • 36. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.
    Shimano H, Namba Y, Ohsuga J, Kawamura M, Yamamoto K, Shimada M, Gotoda T, Harada K, Yazaki Y, Yamada N.
    J Clin Invest; 1994 May 06; 93(5):2215-23. PubMed ID: 8182153
    [Abstract] [Full Text] [Related]

  • 37. Apo E structure determines VLDL clearance and atherosclerosis risk in mice.
    Knouff C, Hinsdale ME, Mezdour H, Altenburg MK, Watanabe M, Quarfordt SH, Sullivan PM, Maeda N.
    J Clin Invest; 1999 Jun 06; 103(11):1579-86. PubMed ID: 10359567
    [Abstract] [Full Text] [Related]

  • 38. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
    Fan J, Ji ZS, Huang Y, de Silva H, Sanan D, Mahley RW, Innerarity TL, Taylor JM.
    J Clin Invest; 1998 May 15; 101(10):2151-64. PubMed ID: 9593771
    [Abstract] [Full Text] [Related]

  • 39. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR, Jong MC, van Goor H, van Luyn MJ, Bloks V, Havinga R, Voshol PJ, Hofker MH, van Dijk KW, Havekes LM, Kuipers F.
    J Biol Chem; 1999 Dec 10; 274(50):35711-8. PubMed ID: 10585451
    [Abstract] [Full Text] [Related]

  • 40. Increased bone formation in mice lacking apolipoprotein E.
    Schilling AF, Schinke T, Münch C, Gebauer M, Niemeier A, Priemel M, Streichert T, Rueger JM, Amling M.
    J Bone Miner Res; 2005 Feb 10; 20(2):274-82. PubMed ID: 15647822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.